APA (7th ed.) Citation
(2026). Multi-omics analysis identifies CCNB1 as a cell cycle factor driving glioblastoma progression and its inhibition by resveratrol. PLOS ONE.
Chicago Style (17th ed.) Citation
"Multi-omics Analysis Identifies CCNB1 as a Cell Cycle Factor Driving Glioblastoma Progression and Its Inhibition by Resveratrol." PLOS ONE 2026.
MLA (9th ed.) Citation
"Multi-omics Analysis Identifies CCNB1 as a Cell Cycle Factor Driving Glioblastoma Progression and Its Inhibition by Resveratrol." PLOS ONE, 2026.
Warning: These citations may not always be 100% accurate.